Department of Medicine, Health Sciences Center, Stony Brook University, Stony Brook, NY 11794-8151, USA.
Hematol Oncol Clin North Am. 2013 Jun;27(3):443-63. doi: 10.1016/j.hoc.2013.03.002. Epub 2013 Apr 9.
Technological advances in protein and genetic analysis have altered the means by which platelet disorders can be characterized and studied in health and disease. When integrated into a single analytical framework, these collective technologies are referred to as systems biology, a unified approach that links platelet function with genomic/proteomic studies to provide insight into the role of platelets in broad human disorders such as cardiovascular and cerebrovascular disease. This article reviews the historical progression of these applied technologies to analyze platelet function, and demonstrates how these approaches can be systematically developed to provide new insights into platelet biomarker discovery.
蛋白质和基因分析技术的进步改变了在健康和疾病中对血小板紊乱进行特征描述和研究的方法。当这些技术被整合到一个单一的分析框架中时,就被称为系统生物学,这是一种将血小板功能与基因组/蛋白质组研究联系起来的统一方法,为理解血小板在广泛的人类疾病(如心血管和脑血管疾病)中的作用提供了深入的认识。本文回顾了分析血小板功能的这些应用技术的历史发展,并展示了如何系统地开发这些方法,以提供对血小板生物标志物发现的新见解。